Sable announce “encouraging assay results”

PUBLISHED: 24 Sep 2013 @ 21:31 | Comments (0) |

Sable Mining Africa (LSE:SBLM), an AIM listed exploration company, has announced “encouraging assay results” from the company’s recently completed expansion exploration programme at the Nimba Iron Ore Project in south-east Guinea (‘Nimba Project’).

In a statement the company cited “results demonstrate high grade canga in the expansion area with best grade and vertical width of 62.0% iron (‘Fe’) over 36.0m (includes 2.8m of cavities)”.

Commenting on the results Sable Mining CEO Andrew Groves said, “These are truly exceptional results, which further underpin our confidence that Nimba has the potential to develop into a world class high tonnage, high grade, high margin and low capex iron ore production asset.

“Our exploration team have made a great deal of progress and have already drilled and successfully converted 135.5Mt of our stated 200Mt exploration target to a resource, and I am confident that we are on course to further delineate the remaining potential in the coming weeks”.

Overview:

•Results received from the first 7 of 30 diamond drill holes on Plateau 2.

•Drilling programme targeting an extension to the area of mineralisation immediately adjacent to the current JORC Code compliant Mineral Resource of 135.5Mt at an in-situ grade of 59.4% (see announcement dated 13 September 2013 for full details).

•Canga mineralised extension area 200m wide and up to 3.9km long, part of a previously announced exploration target potential of between 45Mt and 80Mt of canga on Plateau 2 and Plateau 3.

•Inclusion of extension area exploration target brings total Nimba exploration target to over 200Mt, which the Company is targeting to delineate before the end of Q4 2013.

•48 drill holes completed in extension drilling programme; 18 on Plateau 3 and 30 on Plateau 2 (in addition to five geotechnical boreholes totalling 53 holes as previously referenced).

•Remaining batches from Plateau 2 and Plateau 3 drill holes delivered to Ultratrace laboratory in Perth – further results to be released in due course.

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Plc. ADVFN Plc does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.